SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy

Solventum received FDA clearance to combine Restrata Matrix with V.A.C. Therapy, potentially broadening the wound-care applications for the combination. The clearance may support long-term growth, though the article provides no financial estimates or market reaction.